Support for Stewart, Feder

I congratulate The Scientist on its coverage of the Stewart-Feder case in the May 17 issue, including the statement by the two embattled scientists themselves (page 11), and the thoughtful Commentary by Margot O'Toole (page 12). As might be gathered from my quoted remarks here in the same issue (Franklin Hoke, page 1), I am completely on the side of Stewart and Feder. It is true that they ventured outside biomedical research in using their "plagiarism machine" to examine a biography of Abrah

Written byJohn Edsall
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

It is true that they ventured outside biomedical research in using their "plagiarism machine" to examine a biography of Abraham Lincoln, but this took them only about a month, whereas their work on scientific integrity has been proceeding for more than 10 years. What they did involved a natural extension of scientific curiosity. The NIH authorities, who had been giving their work consistently "excellent" ratings, could have delegated someone to talk with them about the matter, perhaps with advice to get back closer to problems of scientific integrity. Instead, the authorities swooped down upon them, ordered all their files to be locked up, and proposed to reassign them.

I consider this extraordinary punitive action to have been a grave violation of proper relations between administrators and the investigators for whom they are responsible. It is well known that the work of Stewart and Feder is controversial; there are influential people ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies